Literature DB >> 12578795

Proptosis after retrobulbar corticosteroid injections.

Omesh P Gupta1, James R Boynton, Paul Sabini, Walter Markowitch, Vito C Quatela.   

Abstract

PURPOSE: This report describes the clinical, radiographic, and histopathologic findings in patients with proptosis secondary to lipomatosis after retrobulbar corticosteroid injection.
DESIGN: Retrospective, noncomparative, interventional case series and review of the literature.
METHODS: Five patients who developed symptomatic unilateral proptosis after steroid injection were studied and the literature was reviewed.
RESULTS: No previous description was found in the literature. All five cases were studied with computed tomography, and two cases were confirmed with histopathology. No fibrosis or granulomatous inflammation was identified.
CONCLUSIONS: Orbital lipomatosis is a potential complication of retrobulbar steroid injections. Symptomatic relief can be provided by a transconjunctival approach to the lower lid fat compartment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578795     DOI: 10.1016/S0161-6420(02)01743-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

Review 1.  Pharmacological treatments for thyroid eye disease.

Authors:  Sara P Modjtahedi; Bobeck S Modjtahedi; Ahmad M Mansury; Dinesh Selva; Raymond S Douglas; Robert A Goldberg; Igal Leibovitch
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Orbital steroid injections.

Authors:  R A Goldberg
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

3.  Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

Authors:  Rogério A Costa; Rodrigo Jorge; Daniela Calucci; Luiz A S Melo; José A Cardillo; Ingrid U Scott
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02-28       Impact factor: 3.117

4.  Fornix triamcinolone injection for thyroid orbitopathy.

Authors:  Shirin Hamed-Azzam; Abed Mukari; Ilan Feldman; Walid Saliba; Haneen Jabaly-Habib; Daniel Briscoe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-12       Impact factor: 3.117

Review 5.  [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].

Authors:  J B Jonas; I Kreissig; B Kamppeter; R F Degenring
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

6.  Resolution of idiopathic granulomatous orbital inflammation with intraorbital triamcinolone.

Authors:  Elizabeth M McElnea; Sean Hynes; Gerry T Fahy
Journal:  BMJ Case Rep       Date:  2014-03-04

7.  Proptosis with Increased Orbital Fat in an Obese Patient.

Authors:  Azhar Seedat; Shaheen Seedat; Sulaiman E I Moosa
Journal:  Case Rep Radiol       Date:  2020-12-08

Review 8.  Local delivery of corticosteroids in clinical ophthalmology: A review.

Authors:  Adrian T Fung; Tuan Tran; Lyndell L Lim; Chameen Samarawickrama; Jennifer Arnold; Mark Gillies; Caroline Catt; Logan Mitchell; Andrew Symons; Robert Buttery; Lisa Cottee; Krishna Tumuluri; Paul Beaumont
Journal:  Clin Exp Ophthalmol       Date:  2020-01-22       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.